All rare disease medications require a valid prescription from a licensed U.S. prescriber that matches the order exactly. Canada Drugs Online reserves the right to refuse any order if the prescription appears falsified, altered, incomplete, or otherwise invalid. For more information, please review our Prescription Approval Policy.
A "rare disease" is defined in the United States as a condition affecting fewer than 200,000 people. While individually rare, there are over 10,000 rare diseases collectively affecting 30 million Americans. Therapeutic innovations for these conditions, known as "Orphan Drugs," often carry significant clinical specificity.[1]
We help Americans find lower prices on common rare disease and specialized prescriptions, including medications like Evrysdi, Carnitor, Cuprimine, Vimizim, and Mestinon.
Prescription therapies designed for inherited disorders and specific chromosomal conditions
Treatment plans for managing disorders of metabolism and systemic chemical imbalances
Therapies targeting muscular atrophy, nerve-muscle signaling, and motor neuron health
Replacement and supplemental therapies for missing or deficient enzymes within the body
Ensuring consistent access to specialized orphan drugs and high-specialty medications
Every order is vetted by professional liaisons to ensure dosage and strength match the U.S. specialist's intent.
We only accept prescriptions from licensed U.S. providers and strictly monitor for any signs of invalid documentation. [5]
Our affiliated dispensing partners adhere to strict international pharmacy standards for handling specialty medications.
Many rare disease medications, such as Evrysdi or certain enzyme therapies, require refrigeration and precise handling. Always check the storage instructions immediately upon delivery and ensure your shipping address is one where you can receive cold-chain items promptly.[2]
Americans are living with a rare disease, representing a significant portion of the total U.S. population.
Source: FDA [1]Unique rare diseases have been identified, with many still in active clinical research for approved treatments.
Source: NCATS [1]Average increase in medical costs for patients living with rare diseases compared to those without.
Source: NIH Study [7]